April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Prevention of photoreceptor cell degeneration in P23H rats after allele-specific knockdown of mutant Rhodopsin RNA expression using antisense oligonucleotide (ASO) treatment
Author Affiliations & Notes
  • Sue F Murray
    Exploratory Research, ISIS Pharmaceuticals, Carlsbad, CA
  • Ali Jazayeri
    Exploratory Research, ISIS Pharmaceuticals, Carlsbad, CA
  • Matthew M LaVail
    School of Medicine, UCSF, San Francisco, CA
  • Michael T Matthes
    School of Medicine, UCSF, San Francisco, CA
  • Douglas Yasumura
    School of Medicine, UCSF, San Francisco, CA
  • Haidong Yang
    School of Medicine, UCSF, San Francisco, CA
  • Michael McCaleb
    Exploratory Research, ISIS Pharmaceuticals, Carlsbad, CA
  • Raechel Peralta
    Exploratory Research, ISIS Pharmaceuticals, Carlsbad, CA
  • Andy Watt
    Exploratory Research, ISIS Pharmaceuticals, Carlsbad, CA
  • Brett Monia
    Exploratory Research, ISIS Pharmaceuticals, Carlsbad, CA
  • Footnotes
    Commercial Relationships Sue Murray, ISIS Pharmaceuticals (E); Ali Jazayeri, ISIS Pharmaceuticals (E); Matthew LaVail, None; Michael Matthes, None; Douglas Yasumura, None; Haidong Yang, None; Michael McCaleb, ISIS Pharmaceuticals (E); Raechel Peralta, ISIS Pharmaceuticals (E); Andy Watt, ISIS Pharmaceuticals (E); Brett Monia, ISIS Pharmaceuticals (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1258. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sue F Murray, Ali Jazayeri, Matthew M LaVail, Michael T Matthes, Douglas Yasumura, Haidong Yang, Michael McCaleb, Raechel Peralta, Andy Watt, Brett Monia; Prevention of photoreceptor cell degeneration in P23H rats after allele-specific knockdown of mutant Rhodopsin RNA expression using antisense oligonucleotide (ASO) treatment. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1258.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Reducing mutant mRNAs using antisense technology can be a potentially effective therapeutic approach for dominantly inherited diseases. To preserve the photoreceptor cell function and structure in a rodent model of retinitis pigmentosa, P23H-1 transgenic rat, using a potent and selective allele-specific antisense oligonucleotide (ASO) inhibitor targeting the mutant rhodopsin RNA.

Methods: Transgenic rats expressing the murine P23H gene (Line 1) were administered either a mouse specific P23H ASO or non-specific Control ASO in one eye on Day 10 and Day 22 by intravitreal injection (VIT). The contralateral eye was injected with PBS and used as a comparator control. On Day 45, ERG measurements were taken followed by eye enucleation. Half of the rats were designated for retinal outer nuclear layer analysis and the other half for mRNA analysis.

Results: Using an ASO targeting the mouse mutant rhodopsin mRNA, we demonstrated a slower progression of photoreceptor degeneration and improved ERG measurements 30 days after treatment. Eyes injected with P23H ASO had a 128 ± 22% improved amplitude response (scotopic a-wave) as compared to the PBS, while the control ASO, had a 37% ± 9 difference. In addition, morphometric analysis of the outer nuclear layer showed an 18 ± 8% or 5.7 ± 7% greater thickness following treatment with P23H ASO or Control ASO, respectively. Eyes injected with the P23H ASO had greater rat rhodopsin expression, 176 ± 17% as compared to contralateral eye, consistent with the preservation of the photoreceptor cells. In the control ASO group, the rat rhodopsin expression showed very little difference from PBS eye (-2.6± 6%).

Conclusions: Allele-specific ASO mediated knockdown of mutant rhodopsin expression slowed the rate of photoreceptor degeneration and preserved the function of the photoreceptor cells of the P23H transgenic rat. Our data indicate that ASO treatment is a potentially effective therapy for autosomal dominant retinitis pigmentosa.

Keywords: 649 photoreceptors: visual performance • 696 retinal degenerations: hereditary • 702 retinitis  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×